Nanopharm partners with Layden Labs to venture into possible production of nasal spray therapies

UK – Nanopharm, a UK based pharma company, and Leyden Lab, a Dutch based virology drug company, have signed a partnership agreement to develop intranasal spray product candidates that could offer protection against known and new respiratory viruses. Under the partnership, Nanopharm will combine its expertise in the development of nasally delivered drug products with Leyden Labs’ portfolio of nasal spray product candidates. The agreement will utilize Leyden Labs’ platform, which targets commonalities in virus families to develop product candidates that can offer protection against many strains of a virus…

Read More